查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1527085

2024 年骨科生物製品全球市场报告

Orthobiologics Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

骨科生物製剂市场规模预计在未来几年将强劲成长。 2028年，将以6.5%的复合年增长率成长至91.2亿美元。预测期内的增长可能是由人口老龄化和久坐生活方式、先进产品的持续开发、有利的报销政策、新生物矫正产品的监管核准以及现有生物矫正产品适应症的扩大等因素推动的。多种因素有关。预测期内的主要趋势包括再生医学的进步、产品创新、技术进步、策略性倡议和市场扩张。

由于道路事故和运动伤害的发生率不断增加，这往往会导致肌肉骨骼系统损伤，因此骨科生物製剂市场有望成长。这些事故是由多种因素造成的，包括分心驾驶、超速、不利的路况、过度使用、设备不足以及运动伤害预防措施不足等。骨科生物製剂透过使肌肉骨骼组织更快更有效地癒合、减少发炎并增强身体的自然修復过程，在此类损伤的治疗中发挥重要作用。这是透过应用骨移植、生长因子、干细胞和富含血小板的血浆等物质来实现的。例如，2022 年 5 月，美国公路交通安全管理局报告称，2021 年机动车碰撞死亡人数增加了10.5%，达到约42,915 人，而2020 年为38,824 人。增长治疗道路交通和运动伤害。

骨科生物製品市场的主要参与企业正在积极开发先进的解决方案，以改善整形外科手术中的骨癒合和融合。例如，干燥的同种异体移植混合物将坚韧的皮质纤维与矿化皮质骨结合起来，为新骨形成提供结构支撑并促进骨诱导特性。美国生技药品Isto Biologics 于 2024 年 5 月推出了 Fibrant Liberty 移植物。这种移植物整合了坚韧的皮质纤维和矿化的皮质鬆质碎片。一旦水合，这种移植物就会变得柔韧，可用于各种外科手术。更长、更强的纤维可改善处理并形成网络，防止移植物迁移，同时保持结构完整性。

目录

第一章执行概述

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球骨科生物製品市场：驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 全球骨科生物製品市场表现：规模与成长，2018-2023
  • 全球骨科生物製品市场预测：规模与成长，2023-2028 年、2033 年

第六章 市场细分

  • 全球骨科生物製品市场：依产品类型分類的绩效与预测，2018-2023、2023-2028、2033
  • 黏性补充品
  • 骨生长因子
  • 去矿物质骨基质
  • 人工骨替代物
  • 细胞同种异体移植
  • 其他的
  • 全球骨科生物製品市场：按应用、性能和预测，2018-2023、2023-2028、2033
  • 脊椎融合手术
  • 颚颜面和牙齿
  • 软组织修復
  • 重组和骨折手术
  • 其他的
  • 全球骨科生物製品市场：按最终用户、性能和预测，2018-2023、2023-2028、2033
  • 医院
  • 整形外科诊所
  • 门诊手术中心
  • 其他的

第 7 章 区域/国家分析

  • 全球骨科生物製品市场：按地区、绩效及预测，2018-2023、2023-2028、2033
  • 全球骨科生物製品市场：依国家、绩效及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 骨科生物製剂市场：竞争格局
  • 骨科生物製品市场：公司简介
    • Johnson & Johnson
    • Medtronic plc
    • Zimmer Biomet
    • Arthrex Inc.
    • Integra Lifesciences Corporation

第三十一章 其他重大及创新企业

  • NuVasive Inc.
  • Globus Medical
  • Bioventus
  • MTF Biologics
  • ATEC Spine Inc.
  • Exactech Inc.
  • SeaSpine
  • RTI Surgical
  • AlloSource
  • XTANT MEDICAL
  • Spine Wave Inc.
  • Bone Biologics Corp.
  • Locate Bio Limited
  • Wright Medical Group NV
  • BoneSupport AB

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来展望与潜力分析

第36章附录

简介目录
Product Code: r18690

Orthobiologics refer to therapies derived from natural substances utilized in treating various musculoskeletal conditions. These therapies aim to enhance the body's capacity to repair and regenerate bones, cartilage, tendons, and ligaments in orthopedic treatments, ultimately improving recovery times and outcomes in procedures such as spinal fusion, fracture repair, and joint reconstruction.

The main products of orthobiologics include viscosupplements, bone growth factors, demineralized bone matrix, synthetic bone substitutes, cellular allografts, and others. Viscosupplements are gel-like substances injected into joints to provide lubrication and cushioning, thereby reducing pain and enhancing mobility in individuals with osteoarthritis. These products find applications across various fields, including spinal fusion, maxillofacial and dental surgeries, soft tissue repair, reconstructive and fracture surgery, and others. They are utilized by various end users such as hospitals, orthopedic clinics, ambulatory surgery centers, and others.

The orthobiologics market research report is one of a series of new reports from The Business Research Company that provides orthobiologics market statistics, including the orthobiologics industry global market size, regional shares, competitors with orthobiologics market share, detailed orthobiologics market segments, market trends, and opportunities, and any further data you may need to thrive in the orthobiologics industry. These orthobiologics market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The orthobiologics market size has grown strongly in recent years. It will grow from $6.65 billion in 2023 to $7.08 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to several factors, including the rise in the prevalence of orthopedic diseases and conditions, a shift towards minimally invasive procedures, an increase in the number of reconstructive surgeries, higher healthcare expenditure, increased awareness among patients and healthcare providers, and economic development in emerging markets.

The orthobiologics market size is expected to see strong growth in the next few years. It will grow to $9.12 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to factors such as the aging population and sedentary lifestyles, ongoing development of advanced products, favorable reimbursement policies, regulatory approvals for new orthobiologic products, and expanded indications for existing orthobiologic products. Major trends in the forecast period include advancements in regenerative medicine, product innovations, technological advancements, strategic initiatives, and market expansion.

The orthobiologics market is poised for growth due to the increasing incidence of road accidents and sports injuries, which often result in musculoskeletal damage. These incidents are fueled by various factors such as distracted driving, speeding, unfavorable road conditions, overuse, inadequate equipment, and insufficient sports injury prevention measures. Orthobiologics play a crucial role in treating such injuries by facilitating faster and more effective healing of musculoskeletal tissues, reducing inflammation, and enhancing the body's natural repair processes. This is achieved through the application of substances such as bone grafts, growth factors, stem cells, and platelet-rich plasma. For example, in May 2022, the National Highway Traffic Safety Administration reported a 10.5% increase in motor vehicle crash fatalities in 2021, reaching approximately 42,915 deaths compared to 38,824 in 2020, indicating the growing demand for orthobiologics in addressing injuries from road accidents and sports.

Key players in the orthobiologics market are actively developing advanced solutions to improve bone healing and fusion in orthopedic procedures. Dry allograft mixtures, for instance, combine sturdy cortical fibers with mineralized cortical bone, offering structural support and promoting osteoinductive properties for new bone formation. Isto Biologics, a US-based biologics-focused company, introduced Fibrant Liberty allograft in May 2024, featuring robust cortical fibers integrated with mineralized cortical cancellous chips. This graft, upon hydration, becomes pliable and can be tailored for various surgical procedures. Its longer and stronger fibers improve handling and form a network that prevents graft migration while maintaining structural integrity.

In February 2023, Zimmer Biomet Holdings Inc., a US-based medical technology company, completed the acquisition of Embody Inc. for $155 million. This strategic move underscores Zimmer's commitment to investing in areas with significant growth potential and introducing innovations to benefit patients and surgeons. Embody, a US-based soft tissue healing company, specializes in developing and manufacturing collagen-based biologic products for soft tissue augmentation and repair. The acquisition includes Embody's comprehensive portfolio of collagen-based biointegrative solutions aimed at supporting healing in challenging orthopedic soft tissue injuries.

Major companies operating in the orthobiologics market are Johnson & Johnson, Medtronic plc, Zimmer Biomet, Arthrex Inc., Integra Lifesciences Corporation, NuVasive Inc., Globus Medical, Bioventus, MTF Biologics, ATEC Spine Inc., Exactech Inc., SeaSpine, RTI Surgical, AlloSource, XTANT MEDICAL, Spine Wave Inc., Bone Biologics Corp., Locate Bio Limited, Wright Medical Group N.V., BoneSupport AB, Graftys, Regenexx, Acumed LLC, Baxter International Inc., LifeNet Health

North America was the largest region in the orthobiologics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the orthobiologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the orthobiologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The orthobiologics market consists of sales of bone morphogenetic proteins, hyaluronic acid, stem cells, and platelet-rich plasma. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Orthobiologics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on orthobiologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for orthobiologics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The orthobiologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Viscosupplements; Bone Growth Factors; Demineralized Bone Matrix; Synthetic Bone Substitutes; Cellular Allograft; Other Products
  • 2) By Application: Spinal Fusion; Maxillofacial And Dental; Soft Tissue Repair; Reconstructive And Fracture Surgery; Other Applications
  • 3) By End User: Hospitals; Orthopedic Clinics; Ambulatory Surgery Centers; Other End Users
  • Companies Mentioned: Johnson & Johnson; Medtronic plc; Zimmer Biomet; Arthrex Inc.; Integra Lifesciences Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Orthobiologics Market Characteristics

3. Orthobiologics Market Trends And Strategies

4. Orthobiologics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Orthobiologics Market Size and Growth

  • 5.1. Global Orthobiologics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Orthobiologics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Orthobiologics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Orthobiologics Market Segmentation

  • 6.1. Global Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Viscosupplements
  • Bone Growth Factors
  • Demineralized Bone Matrix
  • Synthetic Bone Substitutes
  • Cellular Allograft
  • Other Products
  • 6.2. Global Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Spinal Fusion
  • Maxillofacial And Dental
  • Soft Tissue Repair
  • Reconstructive And Fracture Surgery
  • Other Applications
  • 6.3. Global Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Orthopedic Clinics
  • Ambulatory Surgery Centers
  • Other End Users

7. Orthobiologics Market Regional And Country Analysis

  • 7.1. Global Orthobiologics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Orthobiologics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Orthobiologics Market

  • 8.1. Asia-Pacific Orthobiologics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Orthobiologics Market

  • 9.1. China Orthobiologics Market Overview
  • 9.2. China Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Orthobiologics Market

  • 10.1. India Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Orthobiologics Market

  • 11.1. Japan Orthobiologics Market Overview
  • 11.2. Japan Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Orthobiologics Market

  • 12.1. Australia Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Orthobiologics Market

  • 13.1. Indonesia Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Orthobiologics Market

  • 14.1. South Korea Orthobiologics Market Overview
  • 14.2. South Korea Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Orthobiologics Market

  • 15.1. Western Europe Orthobiologics Market Overview
  • 15.2. Western Europe Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Orthobiologics Market

  • 16.1. UK Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Orthobiologics Market

  • 17.1. Germany Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Orthobiologics Market

  • 18.1. France Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Orthobiologics Market

  • 19.1. Italy Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Orthobiologics Market

  • 20.1. Spain Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Orthobiologics Market

  • 21.1. Eastern Europe Orthobiologics Market Overview
  • 21.2. Eastern Europe Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Orthobiologics Market

  • 22.1. Russia Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Orthobiologics Market

  • 23.1. North America Orthobiologics Market Overview
  • 23.2. North America Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Orthobiologics Market

  • 24.1. USA Orthobiologics Market Overview
  • 24.2. USA Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Orthobiologics Market

  • 25.1. Canada Orthobiologics Market Overview
  • 25.2. Canada Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Orthobiologics Market

  • 26.1. South America Orthobiologics Market Overview
  • 26.2. South America Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Orthobiologics Market

  • 27.1. Brazil Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Orthobiologics Market

  • 28.1. Middle East Orthobiologics Market Overview
  • 28.2. Middle East Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Orthobiologics Market

  • 29.1. Africa Orthobiologics Market Overview
  • 29.2. Africa Orthobiologics Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Orthobiologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Orthobiologics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Orthobiologics Market Competitive Landscape And Company Profiles

  • 30.1. Orthobiologics Market Competitive Landscape
  • 30.2. Orthobiologics Market Company Profiles
    • 30.2.1. Johnson & Johnson
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Medtronic plc
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Zimmer Biomet
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Arthrex Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Integra Lifesciences Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Orthobiologics Market Other Major And Innovative Companies

  • 31.1. NuVasive Inc.
  • 31.2. Globus Medical
  • 31.3. Bioventus
  • 31.4. MTF Biologics
  • 31.5. ATEC Spine Inc.
  • 31.6. Exactech Inc.
  • 31.7. SeaSpine
  • 31.8. RTI Surgical
  • 31.9. AlloSource
  • 31.10. XTANT MEDICAL
  • 31.11. Spine Wave Inc.
  • 31.12. Bone Biologics Corp.
  • 31.13. Locate Bio Limited
  • 31.14. Wright Medical Group N.V.
  • 31.15. BoneSupport AB

32. Global Orthobiologics Market Competitive Benchmarking

33. Global Orthobiologics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Orthobiologics Market

35. Orthobiologics Market Future Outlook and Potential Analysis

  • 35.1 Orthobiologics Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Orthobiologics Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Orthobiologics Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer